Kenzie Maclsaac
Private Equity Investor at Cure Ventures Management LP
Kenzie Maclsaac active positions
Companies | Position | Start | End |
---|---|---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 28/02/2022 | - |
Career history of Kenzie Maclsaac
Former positions of Kenzie Maclsaac
Companies | Position | Start | End |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Director/Board Member | 30/11/2018 | 02/12/2022 |
Fog Pharmaceuticals, Inc.
Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Director/Board Member | 31/03/2018 | 29/11/2018 |
Training of Kenzie Maclsaac
Carleton University | Undergraduate Degree |
University of Toronto | Graduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Statistics
International
United States | 5 |
Canada | 3 |
Operational
Director/Board Member | 2 |
Private Equity Investor | 1 |
Undergraduate Degree | 1 |
Sectoral
Finance | 3 |
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private companies | 2 |
---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
Fog Pharmaceuticals, Inc.
Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Kenzie Maclsaac
- Experience